Filing status
- Accounts due
- 30 April 2027
- Last accounts
- 31 July 2025
- Conf. stmt due
- 15 June 2027
- Last conf. stmt
- 1 June 2026
Enedra Therapeutics Limited
- Incorporated
- 2 June 2021 (5 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Patrick Christian Maurice ChaltinKeith Stuart Blundy
- Owned by
- Andreas Ballis
- Accounts type
- Total exemption full
- Region
- East of England
- Address
- Salisbury HouseStation RoadCambridgeCB1 2LA
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
Director · Appointed 4 September 2025
British
Born May 1971 (55)
Chaltin, Patrick Christian Maurice
Director · Appointed 6 November 2024
Belgian
Born November 1974
Blundy, Keith Stuart
Director · Appointed 11 April 2023
British
Born April 1960 (66)
Moore, Tanya Marie
Director · Appointed 15 October 2021
British
Born May 1975 (51)
Ballis, Andreas
Director · Appointed 2 June 2021
Greek
Born July 1978 (48)
Officer history (3 former)
24 December 2025
Resigned Fletcher, Laura Margaret, Dr as Director
4 September 2025
30 November 2024
Resigned Papenfuss, Kerstin, Dr as Director
6 November 2024
Appointed Chaltin, Patrick Christian Maurice as Director
29 October 2024
Appointed Papenfuss, Kerstin, Dr as Director
11 April 2023
Appointed Blundy, Keith Stuart as Director
4 March 2022
Resigned Gutteridge, Alexander Paul as Director
15 October 2021
Appointed Moore, Tanya Marie as Director
13 October 2021
Appointed Fletcher, Laura Margaret, Dr as Director
2 June 2021
Appointed Ballis, Andreas as Director
2 June 2021
Appointed Gutteridge, Alexander Paul as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Andreas Ballis
Individual · Notified 2 June 2021
Owns 25–50% of shares
Holds 25–50% of voting rights
Greek
Born July 1978 (48)
Former controllers (1)
4 March 2022
Ceased Alexander Paul Gutteridge — Owns 25–50% of shares
Financials
Balance sheet as at 31 July 2025 · total exemption full accounts
- Net Assets
- £388,334
- Cash
- £37,173
- Employees
- 6
- Debt Ratio
- 5%
- Current Ratio
- 20.2x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Fixed Assets | £638 | £937 | £525 | £1,192 |
| Current Assets | £407,858 | £692,779 | £58,114 | £26,102 |
| Cash | £37,173 | £90,374 | £35,135 | £26,026 |
| Creditors (< 1 year) | £20,162 | £639,024 | £112,989 | £12,119 |
| Creditors (> 1 year) | £40,000 | £40,000 | ||
| Net Current Assets | £387,696 | £53,755 | (£54,875) | £13,983 |
| Net Assets | £388,334 | £54,692 | (£94,350) | (£24,825) |
| Shareholder Funds | £388,334 | £54,692 | (£94,350) | (£24,825) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 16 September 2026 | Change of share class name or designation | |||
| 16 September 2026 | Compulsory strike-off action has been discontinued | |||
| 15 September 2026 | First Gazette notice for compulsory strike-off | |||
| 11 September 2026 | Confirmation statement with updates | 1 June 2026 | ||
| 12 August 2026 | Resolutions |
Some other companies at this address
Other companies in this industry
Edinburgh
West Mains Road
Penicuik
Invergowrie
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →